Creutzfeldt‐Jakob disease: Clinical features, epidemiology and tests
- 1 June 1998
- journal article
- review article
- Published by Wiley in Electrophoresis
- Vol. 19 (8-9) , 1306-1310
- https://doi.org/10.1002/elps.1150190815
Abstract
Creutzfeldt‐Jakob disease (CJD) is now recognized to occur in four main forms: classical sporadic, genetic, iatrogenic and new variant. These are briefly described. The evidence that new variant disease is due to bovine spongiform encephalopathy (BSE) is reviewed. In CJD, disease and infectivity are associated with the accumulation of an abnormal form of a normal cellular protein. Protein analysis and the study of the gene which encodes for this protein have therefore played an important role in understanding CJD. Diagnostic tests for CJD are discussed with particular reference to the detection of the 14‐3‐3 protein in the cerebrospinal fluid (CSF).Keywords
This publication has 17 references indexed in Scilit:
- Predicting the CJD epidemic in humansNature, 1997
- Molecular analysis of prion strain variation and the aetiology of 'new variant' CJDNature, 1996
- The 14-3-3 Brain Protein in Cerebrospinal Fluid as a Marker for Transmissible Spongiform EncephalopathiesNew England Journal of Medicine, 1996
- Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variation in the PRNP geneHuman Genetics, 1996
- BSE transmission to macaquesNature, 1996
- A new variant of Creutzfeldt-Jakob disease in the UKPublished by Elsevier ,1996
- "Friendly fire" in medicine: hormones, homografts, and Creutzfeldt-Jakob diseaseThe Lancet, 1992
- Creutzfeldt-Jakob disease in England and Wales, 1980-1984: a case-control study of potential risk factors.Journal of Neurology, Neurosurgery & Psychiatry, 1988
- Abnormal Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt–Jakob DiseaseNew England Journal of Medicine, 1986
- Creutzfeldt-Jakob Disease (Spongiform Encephalopathy): Transmission to the ChimpanzeeScience, 1968